| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $51.0M | — | +151.6% |
| Cost of Revenue | $4.1M | — | +77.6% |
| Gross Profit | $46.8M | — | +161.2% |
| R&D Expense | $15.6M | — | -21.5% |
| SG&A Expense | $51.5M | — | +47.2% |
| Operating Income | -$20.3M | — | +45.1% |
| Pre-tax Income | -$28.3M | — | +34.8% |
| Income Tax | -$4.8M | — | -1317.3% |
| Net Income | -$23.6M | — | +46.2% |
| EPS (Basic) | -$0.47 | — | +48.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $110.0M | -0.7% | +5.7% |
| Short-term Investments | $39.7M | -19.4% | -64.5% |
| Accounts Receivable | $55.4M | +67.5% | +182.2% |
| Inventory | $20.9M | +27.1% | +175.6% |
| Current Assets | $237.5M | +27.7% | +0.1% |
| Total Assets | $253.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$45.3M | — | -7.8% |
| Capital Expenditures | $54K | — | +22.7% |
| Investing Cash Flow | -$20.7M | — | +20.3% |
| Financing Cash Flow | $65.2M | — | — |
| Free Cash Flow | -$45.4M | — | -7.8% |
| +2.5% |
| Current Liabilities | $50.6M | +9.1% | +20.6% |
| Long-term Debt | $200.0M | +60.0% | +63.8% |
| Total Liabilities | $377.9M | +23.5% | +28.5% |
| Stockholders' Equity | -$124.3M | -17.8% | -167.5% |